Insys Therapeutics, Inc. 4
4 · Insys Therapeutics, Inc. · Filed Mar 20, 2015
Insider Transaction Report
Form 4
Babich Michael L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-03-20−5,000→ 38,034 totalExercise: $3.25Exp: 2021-03-27→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2015-03-20$3.25/sh+5,000$16,250→ 207,752 total
Footnotes (1)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 28, 2015.